Letters to the Editor


12:49pm, June 15, 2012

Statins oversold
The article that extols statins’ purported benefits for conditions ranging from infection to cancer (“Another side to statins,” SN: 5/5/12, p. 30) does not reflect the balance of evidence. Both favorable and adverse mechanisms apply. We regularly hear from patients who have suffered serious adverse effects, for whom data had not supported expectation of net benefit with statin use but who were prescribed statins by exuberant physicians influenced by the promise of benefits extolled in worshipful, imbalanced (if well-intentioned) articles like this.
Beatrice A. Golomb, Athena Hathaway Meskimen and Hindu Rao, San Diego, Calif.

This article is available only to subscribing members. Join SSP today or Log in.

More from Science News